Cargando…

NTRK1/TrkA Activation Overrides the G(2)/M-Checkpoint upon Irradiation

SIMPLE SUMMARY: Neuroblastoma (NB) is a solid childhood tumor and needs to be treated with multimodal therapy including radiation in advances stages. TrkA/NTRK1 expression is a hallmark of NB with excellent prognosis, but the impact of TrkA/NTRK1 on radiation response is largely unknown. Here, we re...

Descripción completa

Detalles Bibliográficos
Autores principales: Hassiepen, Christina, Soni, Aashish, Rudolf, Ines, Boron, Vivian, Oeck, Sebastian, Iliakis, George, Schramm, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657035/
https://www.ncbi.nlm.nih.gov/pubmed/34885133
http://dx.doi.org/10.3390/cancers13236023
_version_ 1784612418787213312
author Hassiepen, Christina
Soni, Aashish
Rudolf, Ines
Boron, Vivian
Oeck, Sebastian
Iliakis, George
Schramm, Alexander
author_facet Hassiepen, Christina
Soni, Aashish
Rudolf, Ines
Boron, Vivian
Oeck, Sebastian
Iliakis, George
Schramm, Alexander
author_sort Hassiepen, Christina
collection PubMed
description SIMPLE SUMMARY: Neuroblastoma (NB) is a solid childhood tumor and needs to be treated with multimodal therapy including radiation in advances stages. TrkA/NTRK1 expression is a hallmark of NB with excellent prognosis, but the impact of TrkA/NTRK1 on radiation response is largely unknown. Here, we report that human neuroblastoma cell lines engineered to express TrkA/NTRK1 in tightly controlled systems fail to activate the G2/M cell cycle checkpoint upon irradiation, which recapitulates the effects of ATM or ATR inhibition. Our findings point to a hitherto unrecognized TrkA/NTRK1-mediated wiring of the radiation response in NB cells. ABSTRACT: High expression of the receptor tyrosine kinase TrkA/NTRK1 is associated with a favorable outcome in several solid tumors of childhood including neuroblastoma. During development, TrkA/NTRK1 governs migration and differentiation of neuronal precursor cells, while it is associated with mitotic dysfunction and altered DNA damage response, among others, in neuroblastoma. Here, we used human neuroblastoma cell lines with inducible TrkA/NTRK1 expression to mechanistically explore the role of TrkA/NTRK1 signaling in checkpoint activation after DNA damage induced by ionizing radiation (IR). TrkA/NTRK1 activated cells showed increased short-term cell viability upon IR compared to vector control cells. This was accompanied by a deficient G(2)/M-checkpoint at both low (1 Gy) and high doses (4 Gy) of IR. In a tightly controlled setting, we confirmed that this effect was strictly dependent on activation of TrkA/NTRK1 by its ligand, nerve growth factor (NGF). TrkA/NTRK1-expressing cells displayed impaired ATM and CHK1 phosphorylation, resulting in stabilization of CDC25B. In line with these findings, ATM or ATR inhibition recapitulated the effects of TrkA/NTRK1 activation on the IR-induced G(2)/M-checkpoint. In conclusion, we here provide first evidence for a previously unrecognized function of NTRK signaling in checkpoint regulation and the response to IR.
format Online
Article
Text
id pubmed-8657035
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86570352021-12-10 NTRK1/TrkA Activation Overrides the G(2)/M-Checkpoint upon Irradiation Hassiepen, Christina Soni, Aashish Rudolf, Ines Boron, Vivian Oeck, Sebastian Iliakis, George Schramm, Alexander Cancers (Basel) Article SIMPLE SUMMARY: Neuroblastoma (NB) is a solid childhood tumor and needs to be treated with multimodal therapy including radiation in advances stages. TrkA/NTRK1 expression is a hallmark of NB with excellent prognosis, but the impact of TrkA/NTRK1 on radiation response is largely unknown. Here, we report that human neuroblastoma cell lines engineered to express TrkA/NTRK1 in tightly controlled systems fail to activate the G2/M cell cycle checkpoint upon irradiation, which recapitulates the effects of ATM or ATR inhibition. Our findings point to a hitherto unrecognized TrkA/NTRK1-mediated wiring of the radiation response in NB cells. ABSTRACT: High expression of the receptor tyrosine kinase TrkA/NTRK1 is associated with a favorable outcome in several solid tumors of childhood including neuroblastoma. During development, TrkA/NTRK1 governs migration and differentiation of neuronal precursor cells, while it is associated with mitotic dysfunction and altered DNA damage response, among others, in neuroblastoma. Here, we used human neuroblastoma cell lines with inducible TrkA/NTRK1 expression to mechanistically explore the role of TrkA/NTRK1 signaling in checkpoint activation after DNA damage induced by ionizing radiation (IR). TrkA/NTRK1 activated cells showed increased short-term cell viability upon IR compared to vector control cells. This was accompanied by a deficient G(2)/M-checkpoint at both low (1 Gy) and high doses (4 Gy) of IR. In a tightly controlled setting, we confirmed that this effect was strictly dependent on activation of TrkA/NTRK1 by its ligand, nerve growth factor (NGF). TrkA/NTRK1-expressing cells displayed impaired ATM and CHK1 phosphorylation, resulting in stabilization of CDC25B. In line with these findings, ATM or ATR inhibition recapitulated the effects of TrkA/NTRK1 activation on the IR-induced G(2)/M-checkpoint. In conclusion, we here provide first evidence for a previously unrecognized function of NTRK signaling in checkpoint regulation and the response to IR. MDPI 2021-11-30 /pmc/articles/PMC8657035/ /pubmed/34885133 http://dx.doi.org/10.3390/cancers13236023 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Hassiepen, Christina
Soni, Aashish
Rudolf, Ines
Boron, Vivian
Oeck, Sebastian
Iliakis, George
Schramm, Alexander
NTRK1/TrkA Activation Overrides the G(2)/M-Checkpoint upon Irradiation
title NTRK1/TrkA Activation Overrides the G(2)/M-Checkpoint upon Irradiation
title_full NTRK1/TrkA Activation Overrides the G(2)/M-Checkpoint upon Irradiation
title_fullStr NTRK1/TrkA Activation Overrides the G(2)/M-Checkpoint upon Irradiation
title_full_unstemmed NTRK1/TrkA Activation Overrides the G(2)/M-Checkpoint upon Irradiation
title_short NTRK1/TrkA Activation Overrides the G(2)/M-Checkpoint upon Irradiation
title_sort ntrk1/trka activation overrides the g(2)/m-checkpoint upon irradiation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657035/
https://www.ncbi.nlm.nih.gov/pubmed/34885133
http://dx.doi.org/10.3390/cancers13236023
work_keys_str_mv AT hassiepenchristina ntrk1trkaactivationoverridestheg2mcheckpointuponirradiation
AT soniaashish ntrk1trkaactivationoverridestheg2mcheckpointuponirradiation
AT rudolfines ntrk1trkaactivationoverridestheg2mcheckpointuponirradiation
AT boronvivian ntrk1trkaactivationoverridestheg2mcheckpointuponirradiation
AT oecksebastian ntrk1trkaactivationoverridestheg2mcheckpointuponirradiation
AT iliakisgeorge ntrk1trkaactivationoverridestheg2mcheckpointuponirradiation
AT schrammalexander ntrk1trkaactivationoverridestheg2mcheckpointuponirradiation